Source comparison
CJC-1295 No DAC Legal 2026 Status: Comparison Table
Federal (FDA) Legal for research under 21 CFR 312.2(b)(1) No federal registration Warning letters, product seizure, criminal charges for misbranding Moderate. Targets marketing violations Compliance hinges on labeling and marketing language, not the compound i
This comparison does not assign a generated winner or score.
- Federal (FDA)
- Legal for research under 21 CFR 312.2(b)(1)
- No federal registration
- Warning letters, product seizure, criminal charges for misbranding
- Moderate. Targets marketing violations
- Compliance hinges on labeling and marketing language, not the compound itself
- California
- Legal for research; state registration required for suppliers
- Yes. $2,400 biennial + quarterly reporting
- $5,000/quarter fines, shipment seizures
- High. Active enforcement since Jan 2026
- Non-negotiable for suppliers shipping >100 units/year into CA
- New York
- Legal for research; wholesale license required
- Yes. $1,200 annual wholesale distributor license
- License revocation, shipment seizures
- Moderate. Inconsistent enforcement
- Application backlog makes compliance difficult; enforcement is spotty
- Texas
- Legal for research; supplier registration required
- Yes. $850 annual + initial inspection
- Administrative fines, potential license suspension
- Low. Minimal enforcement observed
- Most cost-effective state registration; worth compliance for volume suppliers
- All Other States
- Legal for research under federal exemption
- No state-level requirements beyond federal compliance
- Federal enforcement only
- Minimal. No state-specific laws as of 2026
- Standard federal compliance sufficient